These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28044258)

  • 1. Tumor vascular infarction: prospects and challenges.
    Jahanban-Esfahlan R; Seidi K; Zarghami N
    Int J Hematol; 2017 Mar; 105(3):244-256. PubMed ID: 28044258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience.
    Bieker R; Kessler T; Schwöppe C; Padró T; Persigehl T; Bremer C; Dreischalück J; Kolkmeyer A; Heindel W; Mesters RM; Berdel WE
    Blood; 2009 May; 113(20):5019-27. PubMed ID: 19179306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of tumor growth by RGD peptide-directed delivery of truncated tissue factor to the tumor vasculature.
    Kessler T; Bieker R; Padró T; Schwöppe C; Persigehl T; Bremer C; Kreuter M; Berdel WE; Mesters RM
    Clin Cancer Res; 2005 Sep; 11(17):6317-24. PubMed ID: 16144936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular infarction by subcutaneous application of tissue factor targeted to tumor vessels with NGR-peptides: activity and toxicity profile.
    Dreischalück J; Schwöppe C; Spieker T; Kessler T; Tiemann K; Liersch R; Schliemann C; Kreuter M; Kolkmeyer A; Hintelmann H; Mesters RM; Berdel WE
    Int J Oncol; 2010 Dec; 37(6):1389-97. PubMed ID: 21042706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of three different targeted tissue factor fusion proteins for inducing tumor vessel thrombosis.
    Hu P; Yan J; Sharifi J; Bai T; Khawli LA; Epstein AL
    Cancer Res; 2003 Aug; 63(16):5046-53. PubMed ID: 12941833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor.
    Brand C; Schliemann C; Ring J; Kessler T; Bäumer S; Angenendt L; Mantke V; Ross R; Hintelmann H; Spieker T; Wardelmann E; Mesters RM; Berdel WE; Schwöppe C
    Oncotarget; 2016 Feb; 7(6):6774-89. PubMed ID: 26735180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-Energy Ultrasound Treatment Improves Regional Tumor Vessel Infarction by Retargeted Tissue Factor.
    Brand C; Dencks S; Schmitz G; Mühlmeister M; Stypmann J; Ross R; Hintelmann H; Schliemann C; Müller-Tidow C; Mesters RM; Berdel WE; Schwöppe C
    J Ultrasound Med; 2015 Jul; 34(7):1227-36. PubMed ID: 26112625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific tissue factor delivery using a tumor-homing peptide for inducing tumor infarction.
    Shi Q; Zhang Y; Liu S; Liu G; Xu J; Zhao X; Anderson GJ; Nie G; Li S
    Biochem Pharmacol; 2018 Oct; 156():501-510. PubMed ID: 30222966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Growth Inhibition via Occlusion of Tumor Vasculature Induced by N-Terminally PEGylated Retargeted Tissue Factor tTF-NGR.
    Brand C; Fröhlich M; Ring J; Schliemann C; Kessler T; Mantke V; König S; Lücke M; Mesters RM; Berdel WE; Schwöppe C
    Mol Pharm; 2015 Oct; 12(10):3749-58. PubMed ID: 26310827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RGD delivery of truncated coagulase to tumor vasculature affords local thrombotic activity to induce infarction of tumors in mice.
    Jahanban-Esfahlan R; Seidi K; Monhemi H; Adli ADF; Minofar B; Zare P; Farajzadeh D; Farajnia S; Behzadi R; Abbasi MM; Zarghami N; Javaheri T
    Sci Rep; 2017 Aug; 7(1):8126. PubMed ID: 28811469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive monitoring of tumor-vessel infarction by retargeted truncated tissue factor tTF-NGR using multi-modal imaging.
    Persigehl T; Ring J; Bremer C; Heindel W; Holtmeier R; Stypmann J; Claesener M; Hermann S; Schäfers M; Zerbst C; Schliemann C; Mesters RM; Berdel WE; Schwöppe C
    Angiogenesis; 2014 Jan; 17(1):235-46. PubMed ID: 24136410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NGR (Asn-Gly-Arg)-targeted delivery of coagulase to tumor vasculature arrests cancer cell growth.
    Seidi K; Jahanban-Esfahlan R; Monhemi H; Zare P; Minofar B; Daei Farshchi Adli A; Farajzadeh D; Behzadi R; Mesgari Abbasi M; Neubauer HA; Moriggl R; Zarghami N; Javaheri T
    Oncogene; 2018 Jul; 37(29):3967-3980. PubMed ID: 29662195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-factor fusion proteins induce occlusion of tumor vessels.
    Schwöppe C; Kessler T; Persigehl T; Liersch R; Hintelmann H; Dreischalück J; Ring J; Bremer C; Heindel W; Mesters RM; Berdel WE
    Thromb Res; 2010 Apr; 125 Suppl 2():S143-50. PubMed ID: 20433995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor rim cells: From resistance to vascular targeting agents to complete tumor ablation.
    Seidi K; Jahanban-Esfahlan R; Zarghami N
    Tumour Biol; 2017 Mar; 39(3):1010428317691001. PubMed ID: 28351332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Tissue Factor to Tumor Vasculature to Induce Tumor Infarction.
    Berdel AF; Schwöppe C; Brand C; Harrach S; Brömmel K; Hintelmann H; Lenz G; Liersch R; Heinzow H; Schliemann C; Mesters RM; Berdel WE; Kessler T
    Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34200318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature.
    Huang X; Molema G; King S; Watkins L; Edgington TS; Thorpe PE
    Science; 1997 Jan; 275(5299):547-50. PubMed ID: 8999802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pHLIP-mediated targeting of truncated tissue factor to tumor vessels causes vascular occlusion and impairs tumor growth.
    Li S; Tian Y; Zhao Y; Zhang Y; Su S; Wang J; Wu M; Shi Q; Anderson GJ; Thomsen J; Zhao R; Ji T; Wang J; Nie G
    Oncotarget; 2015 Sep; 6(27):23523-32. PubMed ID: 26143637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor infarction by targeting tissue factor to tumor vasculature.
    Thorpe PE; Ran S
    Cancer J; 2000 May; 6 Suppl 3():S237-44. PubMed ID: 10874493
    [No Abstract]   [Full Text] [Related]  

  • 19. Infarction of solid Hodgkin's tumors in mice by antibody-directed targeting of tissue factor to tumor vasculature.
    Ran S; Gao B; Duffy S; Watkins L; Rote N; Thorpe PE
    Cancer Res; 1998 Oct; 58(20):4646-53. PubMed ID: 9788617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue factor and fibrin in tumor angiogenesis.
    Fernandez PM; Patierno SR; Rickles FR
    Semin Thromb Hemost; 2004 Feb; 30(1):31-44. PubMed ID: 15034796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.